Rockefeller Capital Management’s AdaptHealth AHCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$13.1K Sell
1,098
-1,487
-58% -$15.2K ﹤0.01% 3878
2025
Q4
$25.7K Buy
2,585
+2,100
+433% +$20.1K ﹤0.01% 3395
2025
Q3
$4.34K Buy
+485
New +$4.49K ﹤0.01% 3905
2022
Q2
Sell
-95
Closed -$1K 4077
2022
Q1
$1K Sell
95
-700
-88% -$12.6K ﹤0.01% 3690
2021
Q4
$19K Hold
795
﹤0.01% 2661
2021
Q3
$18K Buy
795
+359
+82% +$8.68K ﹤0.01% 2621
2021
Q2
$11K Buy
436
+41
+10% +$1.17K ﹤0.01% 2728
2021
Q1
$14K Buy
395
+95
+32% +$3.35K ﹤0.01% 2434
2020
Q4
$11K Buy
+300
New +$9.28K ﹤0.01% 2193

Other funds holding AHCO

Rockefeller Capital Management's AHCO Position: Q1 2026 in Review

Rockefeller Capital Management reduced its AdaptHealth (AHCO) stake by 58% in Q1 2026, selling an estimated $15.2K and leaving 1,098 shares worth $13.1K. The position accounts for ﹤0.01% of the portfolio, ranked #3878.

Rockefeller Capital Management first reported a position in AHCO in Q4 2020 and has held it in 9 quarters since. The position peaked at $25.7K in Q4 2025. 241 funds tracked by Wall St. Rank hold AHCO as of Q1 2026.

  • Rockefeller Capital Management held 1,098 shares of AdaptHealth worth $13.1K as of Q1 2026.
  • Rockefeller Capital Management sold 1,487 AdaptHealth shares in Q1 2026, an estimated $15.2K.
  • AdaptHealth made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q1 2026, its #3878 holding.
  • Rockefeller Capital Management first reported a position in AdaptHealth in Q4 2020 and has held it in 9 quarters since.
  • Rockefeller Capital Management's AdaptHealth position peaked at $25.7K in Q4 2025.
  • 241 funds tracked by Wall St. Rank held AdaptHealth as of Q1 2026.

Based on Rockefeller Capital Management's 13F filing for Q1 2026, filed 14 May 2026.